(Q40547817)

English

Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjects

scientific article published on November 7, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjects (English)

1 reference

Europe PubMed Central

21 September 2017

lipopolysaccharide

0 references

human subject research project

0 references

membrane protein

1 reference

based on heuristic

inferred from title

Escherichia coli

object named as

Escherichia coli

1 reference

based on heuristic

inferred from title

molecular medicine

1 reference

10.1016/S0264-410X(03)00483-3

https://api.crossref.org/works/10.1016/S0264-410X(03)00483-3

24 March 2024

2

object named as

Steven M Opal

1 reference

Europe PubMed Central

21 September 2017

3

object named as

John E Palardy

1 reference

Europe PubMed Central

21 September 2017

author name string

Christian Huber

6

1 reference

Europe PubMed Central

21 September 2017

Pamela Cook

7

1 reference

Europe PubMed Central

21 September 2017

Alan S. Cross

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14575770

24 March 2024

Steven M. Opal

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14575770

24 March 2024

Joseph J. Drabick

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14575770

24 March 2024

H. Shaw Warren

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14575770

24 March 2024

Apurba K. Bhattacharjee

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14575770

24 March 2024

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

21 September 2017

7 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14575770

24 March 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0264410X03004833?httpAccept=text/xml

1 reference

10.1016/S0264-410X(03)00483-3

https://api.crossref.org/works/10.1016/S0264-410X(03)00483-3

24 March 2024

https://api.elsevier.com/content/article/PII:S0264410X03004833?httpAccept=text/plain

1 reference

10.1016/S0264-410X(03)00483-3

https://api.crossref.org/works/10.1016/S0264-410X(03)00483-3

24 March 2024

1 reference

Europe PubMed Central

21 September 2017

21

1 reference

Europe PubMed Central

21 September 2017

31

1 reference

Europe PubMed Central

21 September 2017

4576-4587

1 reference

Europe PubMed Central

21 September 2017

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of bacterial sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The mortality of hospital-acquired bloodstream infections: need for a new vital statistic?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of Gram-Negative Septic Shock with Human IgG Antibody to Escherichia coli J5: A Prospective, Double-Blind, Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A New Method for the Extraction of R Lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Human bactericidal antibody response to meningococcal outer membrane protein vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Complex of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Colorimetric Method for Determination of Sugars and Related Substances

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of the human antibody response to an Escherichia coli O111:B4 (J5) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization with rough mutants of Salmonella minnesota: initial studies in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of an Opsonophagocytic Assay and IgG ELISA to Assess Responses to Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccines in Children and Young Adults with Sickle Cell Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of antibody responses to pneumococcal vaccines with ELISA and opsonophagocytic assay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900483-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(03)00483-3

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40547817&oldid=2109873846"